The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Pharmaceuticals industry for Tuesday, May 13, 2025. Let’s take ...

New research by scientists at the University of Toronto and the Structural Genomics Consortium has deepened our understanding ...

Cells have a trick called splicing. They can cut a gene's message into pieces and decide which fragments to keep. By mixing ...

Metastatic colorectal cancer (mCRC) continues to pose a clinical and commercial challenge, with low 5-year survival rates and limited durable responses to existing therapies. While standard ...

Eukaryogenesis occurred suddenly, driven by the growing length of genes and the limitations on producing longer proteins. An ...

Accumulating evidence suggests that the immune system plays a crucial role in the emergence of atherosclerotic cardiovascular ...

Interim analysis focused on disease-free survival (“DFS”) in randomized Phase 2 AMPLIFY-7P clinical trial expected in Q3 2025 Company has a ...

Researchers confirm and explore the role of estrogen-related receptors in regulating energy production in muscle cells during exercise. The findings indicate that developing a drug to boost ...